safeti
efficaci
profil
oral
administ
bovin
interferon
ifn
alpha
document
mechan
result
clinic
benefit
remain
elus
one
approach
delin
molecular
pathway
ifn
efficaci
use
gene
express
profil
technolog
proofofconcept
studi
differ
unit
oral
dose
natur
bovin
ifn
type
test
cattl
determin
oral
ifn
alter
express
gene
may
pivot
develop
system
resist
viral
infect
footandmouth
diseas
fmd
oral
ifn
administ
twice
time
h
later
blood
collect
h
first
ifn
administr
dna
isol
peripher
blood
mononuclear
cell
pbmc
employ
quantit
polymeras
chain
reaction
qpcr
microarray
assay
within
h
unit
oral
ifn
induc
signific
p
chang
express
test
autoimmun
inflammatori
responseassoci
gene
data
suggest
oral
administ
ifn
viabl
approach
provid
shortterm
antivir
immun
livestock
expos
virus
fmd
viru
fmdv
time
effect
vaccin
produc
distribut
produc
oral
administ
bovin
natur
interferon
ifn
viabl
candid
therapeut
agent
control
viral
diseas
livestock
year
experi
therapeut
effect
human
administ
oral
livestock
companion
anim
indic
oral
safe
efficaci
cummin
et
al
cummin
et
al
cummin
stewart
georgiad
fulton
et
al
georgiad
fleischmann
moor
et
al
moor
et
al
amadori
et
al
mechan
action
welldocu
system
benefici
effect
oral
administ
ifn
still
understood
although
shown
contact
oral
caviti
amplifi
ifnmedi
therapeut
effect
via
interact
mononuclear
cell
oralpharyng
mucosa
eid
et
al
tovey
mauri
tovey
et
al
tovey
et
al
dron
et
al
studi
action
ifnstimul
gene
isg
protein
product
result
fundament
discoveri
relev
translat
control
regul
rna
stabil
edit
protein
transport
turnov
antivir
cellular
action
select
potent
isg
part
critic
pathway
antivir
action
thu
critic
improv
clinic
applic
ifn
borden
william
protein
encod
isg
individu
degrad
variou
viral
rna
block
viral
transcript
inhibit
translat
andor
modifi
protein
assembl
step
viral
replic
releas
borden
william
isg
upregul
human
within
hour
oral
administr
brod
et
al
smith
et
al
anoth
studi
cattl
cdna
microarray
technolog
use
help
identifi
appropri
target
therapeut
intervent
calv
given
low
dose
unit
oral
daili
day
microarray
analysi
perform
gene
namangala
et
al
author
identifi
profil
gene
alter
h
final
oral
dose
ifn
major
gene
fold
degre
chang
least
increas
express
lowdos
oral
unit
suppress
express
gene
alter
alter
gene
test
oral
alter
express
gene
associ
innat
immun
antigen
present
lymphocyt
activ
immun
modul
blood
coagul
hematopoiesi
apoptosi
nonimmunolog
function
repres
alter
gene
test
namangala
et
al
author
comment
observ
repress
gene
transcript
show
pleiotrop
natur
ifn
stimul
gene
suppress
other
thu
reason
hypothes
oral
lowdos
bovin
ifn
capabl
alter
gene
group
affect
lowdos
oral
purpos
present
studi
determin
lowdos
oral
bovin
ifn
would
benefici
biolog
effect
bovin
immun
respons
gene
express
cattl
studi
report
herein
express
immun
responserel
gene
analyz
mode
action
oral
ifn
gene
express
peripher
blood
mononuclear
cell
pbmc
evalu
assess
ifn
effect
famili
gene
kyoto
encyclopedia
gene
genom
kegg
cytokinecytokin
receptor
interact
pathway
natur
bovin
ifn
type
alpha
obtain
colorado
serum
compani
denver
co
bovin
blood
collect
imuflex
wbrp
blood
bag
system
turumo
corpor
tokyo
japan
filter
collect
white
blood
cell
wbc
red
blood
cell
discard
filter
contain
wbc
incub
isol
usa
bluetongu
viru
btv
induc
ifn
product
isol
wbc
acid
treatment
ph
min
use
inactiv
btv
result
ifn
product
use
vivo
treatment
calv
mixtur
ifn
subspeci
ifn
antivir
activ
titer
determin
vesicular
stomat
viru
vsv
plaqu
reduct
assay
rosenquist
loan
cell
cultur
madin
darbi
bovin
kidney
mdbk
cell
titer
bovin
ifn
calcul
standard
method
epstein
ifnneg
control
solut
vv
fetal
calf
serum
normal
salin
solut
also
use
diluent
three
ifn
dose
use
ifn
concentr
unitsml
use
prepar
three
ifn
treatment
dose
final
concentr
unitscalf
sixteen
holstein
steer
calv
kg
bodi
weight
randomli
allot
control
ifn
treatment
group
unit
calv
per
group
calv
group
given
placebo
diluent
ifn
dose
twice
h
day
one
studi
anim
receiv
total
ml
administ
oral
caviti
steril
dispos
syring
calcul
final
amount
ifn
given
group
unitskg
base
mean
weight
per
group
bodi
weight
rectal
temperatur
also
record
ifn
treatment
h
unclot
blood
calf
collect
bd
vacutain
cpt
cell
prepar
tube
becton
dickinson
compani
franklin
lake
nj
h
isol
bovin
rna
beech
tree
laboratori
btl
provid
ri
unclot
blood
also
collect
redtop
bd
vacutain
tube
edta
tube
complet
blood
count
cbc
blood
chemistri
respect
conduct
texa
veterinari
medic
diagnost
laboratori
tvmdl
amarillo
tx
bloodfil
bd
vacutain
cpt
tube
contain
leukocyt
separ
medium
thixotrop
polyest
gel
ficollhypaqu
centrifug
rpm
min
separ
erythrocyt
leukocyt
onehalf
plasma
remov
aspir
remain
plasma
use
resuspend
enrich
leukocyt
surfac
polyest
gel
leukocyterich
plasma
dilut
ml
final
volum
phosphatebuff
salin
ml
conic
centrifug
tube
kept
ice
bath
prior
centrifug
rpm
x
min
centrifug
supernat
aspir
cell
pellet
gentli
resuspend
aliquot
supernat
transfer
vial
cold
trizol
reagent
invitrogen
carlsbad
ca
ad
mlvial
lyse
cell
vial
store
shipment
dri
ice
btl
twotenth
ml
reagentgrad
chloroform
ad
rapidli
thaw
vial
contain
cell
lysat
vortex
min
cap
vial
centrifug
min
aqueou
phase
contain
solubl
rna
transfer
fresh
ml
vial
rna
precipit
solut
ml
isopropyl
alcohol
sampl
held
min
centrifug
min
rna
pellet
wash
vv
ethanol
follow
centrifug
min
wash
repeat
result
rna
pellet
airdri
min
dissolv
nucleasefre
water
bioanalyz
agil
rna
nano
kit
agil
technolog
santa
clara
ca
autom
bioanalyt
devic
use
microfluid
technolog
provid
electrophoret
separ
autom
reproduc
manner
tini
amount
rna
sampl
separ
channel
microfabr
chip
accord
molecular
weight
subsequ
detect
via
laserinduc
fluoresc
result
visual
electropherogram
amount
measur
fluoresc
correl
amount
rna
given
size
imbeaud
et
al
rna
sampl
g
treat
genom
dna
gdna
elimin
buffer
qiagen
valencia
ca
incub
multigen
tm
mini
thermocycl
labnet
edison
nj
min
digest
residu
bovin
gdna
contamin
complementari
dna
cdna
synthes
isol
bovin
rna
use
rt
first
strand
kit
qiagen
accord
protocol
provid
manufactur
cdna
synthes
g
total
rna
combin
taqman
gene
express
master
mix
load
taqman
array
micro
fluidic
card
life
technolog
carlsbad
ca
ninetysix
inventori
bovin
gene
assay
select
four
differ
molecular
pathway
immun
respons
ir
inflamm
cytokin
cy
chemokin
ch
four
gene
actb
gapdh
gusb
alloc
intern
housekeep
control
realtim
pcr
use
taqman
array
micro
fluidic
card
measur
gene
express
cdna
librari
prepar
pbmc
rna
process
accord
manufactur
protocol
reaction
execut
appli
biosystem
viia
tm
realtim
pcr
system
life
technolog
cycl
threshold
ct
valu
obtain
qpcr
reaction
upload
webbas
softwar
provid
qiagen
ct
valu
normal
housekeep
gene
signal
gene
evalu
within
treatment
group
fold
chang
gene
express
calcul
rel
h
control
valu
result
data
reflect
level
express
upregul
downregul
variou
gene
function
ifn
effect
versu
control
valu
gene
calf
serv
control
addit
data
evalu
select
gene
interest
accomplish
use
review
scientif
literatur
pubm
http
wwwncbinlmnihgovpubm
coupl
use
databas
annot
visual
integr
discoveri
david
program
huang
et
al
huang
et
al
jiao
et
al
data
analyz
complet
random
design
model
ijk
trt
timej
e
ijk
mean
separ
protect
least
signific
differ
lsd
treatment
within
time
test
signific
p
chang
differ
gene
express
h
analyz
chi
squar
analysi
twotail
ttest
perform
determin
statist
signific
p
gene
foldchang
result
gene
regard
upregul
downregul
fold
chang
rel
control
statist
signific
p
tabl
summar
express
gene
test
whose
product
particip
within
four
differ
overlap
molecular
pathway
cellular
activ
ir
cy
ch
significantli
p
modifi
ifn
h
tabl
show
qpcr
fold
regul
data
individu
gene
whose
express
significantli
p
alter
unit
ifn
overal
analyz
gene
gene
affect
placebo
one
concentr
oral
administ
ifn
ifn
treatment
group
modest
chang
note
six
irrel
gene
h
sampl
placebotr
control
calv
five
gene
downregul
h
two
five
downregul
h
one
gene
upregul
h
h
postfirst
ifn
treatment
ir
gene
significantli
p
downregul
calv
given
unit
ifn
express
one
gene
selp
significantli
upregul
second
dose
given
h
downregul
express
six
gene
h
later
calv
given
unit
ifn
gene
significantli
p
upregul
rel
control
h
gene
downregul
one
upregul
gene
h
remain
elev
h
two
gene
downregul
h
remain
downregul
h
h
one
addit
upregul
ir
gene
five
addit
downregul
ir
gene
identifi
highest
dose
ifn
test
unit
yield
five
chang
gene
express
h
two
gene
upregul
three
gene
downregul
one
gene
upregul
h
modif
gene
express
evalu
h
h
second
dose
ifn
effect
gene
express
note
h
seen
regardless
ifn
dose
given
one
gene
common
two
treatment
group
administ
either
unit
ifn
downregul
unit
ifn
upregul
unit
ifn
observ
differ
irrel
gene
express
versu
unit
ifn
evalu
use
pathway
analysi
softwar
specif
david
program
use
bo
tauru
genom
baselin
background
control
downregul
unit
h
gene
analyz
function
annot
tool
david
two
major
function
categori
identifi
david
enrich
analysi
receptor
protein
gene
nine
glycoprotein
receptor
gene
ten
analys
aggreg
gene
gene
product
function
implic
reveal
receptor
gene
perform
essenti
ident
function
tabl
list
ten
downregul
gene
whose
product
identifi
receptor
andor
bind
ligand
glycoprotein
david
gene
ontogeni
enrich
analysi
program
identifi
six
gene
code
gene
product
involv
ir
pathway
fa
gene
ontogeni
enrich
analysi
molecular
function
program
within
david
yield
four
gene
whose
product
cytokin
molecul
cytokinelik
activ
three
gene
whose
product
cytokin
bind
cytokin
receptor
activ
addit
analys
gene
pbmc
calv
given
unit
ifn
use
david
program
identifi
kegg
pathway
identifi
seven
downregul
gene
locat
within
specif
familiessubfamili
kegg
cytokin
cytokin
receptor
interact
pathway
includ
hematopoietin
pdgf
tnf
famili
chemokin
cxc
subfamili
tabl
seven
genesgen
product
downregul
unit
ifn
part
singl
kegg
pathway
cytokin
cytokin
receptor
interact
analys
appli
genesgen
product
alter
primarili
upregul
pbmc
calv
given
unit
ifn
function
analysi
biolog
process
yield
genesgen
product
involv
regul
cell
prolifer
andor
cellular
local
molecular
function
analysi
identifi
genesgen
product
cytokin
activ
kegg
pathway
analysi
yield
genesgen
product
within
kegg
pathway
cytokin
cytokin
receptor
interact
tabl
kegg
pathway
identifi
seven
genesgen
product
treatment
group
five
upregul
gene
present
within
three
specif
famili
within
kegg
pathway
ifn
schemat
pictur
kegg
cytokinecytokin
receptor
interact
gene
relat
visual
http
wwwgenomejpkeggbinshow
pathway
queri
auto
imag
show
descript
multi
queri
signific
chang
note
cbc
ifn
treatment
group
chemistri
panel
indic
creatin
kinas
level
decreas
calv
given
oral
ifn
compar
placebo
h
howev
chang
statist
signific
data
shown
oral
ifn
markedli
alter
express
gene
associ
immun
respons
within
h
ifn
administr
moreov
effect
system
chang
gene
express
detect
pbmc
directli
associ
ifntreat
oral
mucosa
seven
downregul
five
upregul
genesgen
product
modul
unit
oral
administ
ifn
shown
part
kegg
pathway
cytokin
cytokin
receptor
interact
critic
earli
recognit
respons
phase
innat
adapt
immun
ifnrespons
genesgen
product
belong
differ
famili
genesproduct
within
kegg
pathway
effect
oral
ifn
express
specif
cytokinecytokin
interact
gene
identifi
studi
merit
investig
one
concern
involv
upregul
ifn
two
gene
encod
cytokin
cytokin
receptor
respect
known
antiinflammatori
effect
wherea
ifn
notabl
ifngamma
thought
favor
immun
respons
kidd
treatment
ifn
ph
inactiv
ifngamma
ifnbeta
howev
ifn
type
alpha
use
studi
pleiotrop
biolog
activ
includ
antivir
activ
antiprolif
effect
stimul
cytotox
activ
pestka
pestka
et
al
fact
type
ifninduc
product
receptor
report
literatur
piazzolla
et
al
leve
et
al
corr
et
al
touzot
et
al
data
suggest
subspeci
ifn
present
exist
formul
isar
affect
gene
express
importantli
data
provid
direct
evid
system
modul
immun
respons
low
dose
oral
administ
ifn
outbr
domest
anim
speci
system
activ
protect
antivir
effect
appear
extend
variou
aspect
innat
develop
immun
respons
expect
provid
addit
system
benefici
effect
fmdvchalleng
livestock
viral
infecti
diseas
anim
cummin
et
al
fmdv
viral
pathogen
rumin
swine
icosahedr
nm
singlestrand
rna
viru
genu
aphtoviru
famili
picornavirida
among
distinct
strain
serotyp
recogn
c
south
african
territori
sat
sat
sat
preval
serotypesstrain
vari
geograph
region
fmdv
type
preval
depend
upon
strain
speci
affect
morbid
may
reach
mortal
adult
typic
less
young
anim
develop
fmdvassoci
myocard
endocard
like
die
direct
effect
fmdv
infect
alexandersen
et
al
grubman
baxt
cattl
typic
present
fever
anorexia
reduct
milk
product
excess
salvat
often
seen
vesicular
lesion
develop
mucou
membran
interdigit
space
coronari
band
within
two
three
day
infect
swine
vesicular
lesion
develop
coronari
band
may
also
found
snout
udder
hock
elbow
smaller
ungul
sheep
goat
develop
mild
vesicl
oral
caviti
bulb
heel
coronari
band
alexandersen
et
al
vesicl
contain
infecti
virion
ruptur
one
two
day
format
facilit
spread
infect
anim
contamin
environ
particular
concern
fmdv
potenti
advers
econom
impact
upon
livestock
product
also
embargo
place
upon
us
canadian
meat
product
prepar
export
fmd
occur
north
america
last
fmd
outbreak
us
last
outbreak
canada
fenner
et
al
howev
sever
recent
fmdv
outbreak
occur
outsid
us
oie
like
recent
experi
novel
swine
coronavirus
stevenson
et
al
could
easili
reach
north
america
serotypespecif
vaccin
control
fmdv
strain
within
serotyp
respons
vaccin
new
fmdv
strain
may
emerg
mutat
usda
thu
fmdv
control
contain
time
may
lost
strainspecif
vaccin
produc
distribut
administ
suscept
livestock
accordingli
effect
antivir
therapeut
agent
would
use
control
fmdv
outbreak
vaccin
avail
known
fmdv
inhibit
ifn
richmond
hamilton
richmond
campbel
convers
part
intracellular
replic
strategi
fmdv
known
inhibit
product
intracellular
ifnalphabeta
chinsangaram
et
al
via
doublestrand
ds
rna
viral
intermedi
block
intracellular
dsrnadepend
protein
kinas
r
pkr
central
intracellular
ifninduc
antivir
pathway
chinsangaram
et
al
stabl
resistancerel
calcium
bind
protein
sorcin
interact
fmdv
protein
inhibit
type
ifn
respons
thu
induct
endogen
ifn
treatment
exogen
ifn
could
help
control
fmdv
field
condit
provid
ifn
otherwis
block
block
fmdv
antiifn
mechan
infecti
bovin
rhinotrach
ibr
herpesviru
coital
vesicular
exanthema
virus
inhibit
fmdv
infect
ifn
induct
straub
ahl
similarli
synthet
ifn
induc
poli
c
andor
iclc
inhibit
fmdv
anim
model
fmdv
infect
richmond
hamilton
richmond
campbel
fmdv
pig
cunliff
et
al
dia
et
al
diazsan
segundo
et
al
relat
ifn
induct
strategi
use
recombin
replicationdefect
virus
contain
ifn
product
gene
within
viral
genom
wu
et
al
mora
et
al
dia
et
al
dia
et
al
perezmartin
et
al
chemic
ifn
induc
toxic
use
manag
fmdv
livestock
mcvicar
et
al
cunliff
et
al
poli
iclc
poli
c
report
effect
adjuv
fmdv
vaccin
diazsan
segundo
et
al
regardless
toxic
factor
viral
ifn
induct
mcvicar
et
al
precis
cellular
molecular
mechan
action
ifn
fmdv
known
correl
report
protect
specif
isg
upregul
tissuespecif
infiltr
dendrit
cell
natur
killer
cell
mora
et
al
diazsan
segundo
et
al
furthermor
studi
note
ifn
induct
may
also
regul
express
immunoregulatori
cytokin
chemokineand
ifnstimul
gene
contribut
prevent
decreas
durat
sever
fmdv
infect
fmdv
shed
environ
diazsan
segundo
et
al
administr
exogen
ifn
atrisk
livestock
popul
face
fmdv
outbreak
repres
attract
inexpens
altern
induct
endogen
ifn
chemic
biolog
recombin
mean
base
data
studi
benefit
occur
within
h
day
case
viral
induc
effect
ifn
wide
avail
purifi
form
naturallyoccur
also
purifi
recombin
molecul
import
attribut
ifn
famili
asid
ifn
gamma
ifn
particularli
speciesspecif
biolog
action
rather
variabl
speciesrestrict
presum
cellular
receptor
subfamili
larg
conserv
across
speci
exampl
human
cell
respons
animalorigin
ifn
mani
anim
cell
respons
natur
recombin
cummin
et
al
bovineorigin
activ
vitro
primat
tovey
et
al
porcin
gressor
et
al
human
cell
cultur
gressor
et
al
carter
porcin
activ
equin
bovin
human
cell
cultur
carter
carter
et
al
activ
porcin
bovin
gressor
et
al
carter
carter
et
al
branca
meister
et
al
chamber
et
al
pestka
felin
desmyt
stewart
cell
cultur
addit
activ
fmdv
oral
benefici
given
cattl
ship
fever
pneumonia
complex
cattl
challeng
virul
ibr
viru
hemotrop
protozoan
parasit
theileria
parva
cummin
hutcheson
georgiad
cummin
et
al
four
studi
benefici
oral
dose
iu
per
calf
compar
favor
activ
dose
present
studi
central
question
rais
studi
follow
low
dose
ifn
given
oral
exert
divers
system
benefici
immunomodulatori
effect
avail
data
suggest
oral
administ
bound
tonsil
associ
lymphoid
dendrit
cell
aggreg
oral
pharyng
caviti
beilharz
et
al
cascad
secondari
cytokin
chemokin
signal
releas
pleiotrop
system
effect
exampl
given
oral
upregul
antivir
mx
gene
activ
murin
splenocyt
human
pbmc
brod
et
al
twoprimefiveprim
adenyl
synthetas
wellcharacter
induc
intracellular
enzym
ifninduct
pathway
johnson
et
al
activ
system
oral
caviti
mice
guinea
pig
given
oral
ifn
satoh
et
al
human
smith
et
al
murin
eid
et
al
tovey
et
al
tovey
et
al
dron
et
al
gene
also
upregul
oral
oronas
administ
murin
ifn
possibl
someth
ifn
may
caus
modul
gene
express
document
studi
possibl
consid
reject
placebo
control
solut
also
use
diluent
multipl
peerreview
scientif
report
indic
low
dose
higher
dose
oral
ifn
benefici
effect
upon
differ
diseas
cattl
hors
moor
et
al
moor
et
al
swine
cummin
et
al
mice
tanakakataoka
et
al
cat
cummin
et
al
poultri
fulton
et
al
human
ship
et
al
present
studi
data
show
unit
bovin
ifn
neglig
effect
gene
express
find
consist
clinic
observ
higher
dose
oral
provid
addit
benefici
immunomodulatori
effect
may
fact
advers
consequ
anim
treat
higher
dose
studi
oral
ifn
markedli
alter
express
gene
associ
immun
respons
within
h
ifn
administr
moreov
effect
system
chang
gene
express
detect
pbmc
remot
oral
mucosa
yet
known
downregul
gene
unit
upregul
gene
unit
repres
biphas
dose
respons
gene
express
effect
tempor
natur
similar
studi
employ
two
dose
sampl
collect
multipl
time
point
h
could
yield
inform
matter
result
also
show
littl
effect
ifn
gene
express
sampl
collect
h
ie
h
second
ifn
dose
administ
h
known
howev
whether
second
dose
ifn
ineffect
sampl
collect
match
time
point
use
sampl
collect
first
dose
studi
note
rel
rapid
effect
oral
dose
isg
upregul
human
within
hour
oral
administr
brod
et
al
smith
et
al
kda
isg
protein
upregul
human
buccal
epitheli
cell
vivo
vitro
peak
level
occur
two
hour
oral
exposur
smith
et
al
short
data
suggest
dose
ifn
critic
modul
gene
express
rel
narrow
window
therapeut
effect
thu
becom
import
ascertain
whether
dose
oral
ifn
suppli
cattl
water
feed
cattl
adequ
control
difficult
expens
timeconsum
catch
restrain
livestock
administ
parenter
antifmdv
vaccin
medic
given
feed
water
ifn
may
fast
inexpens
aid
fmd
control
effect
oral
ifn
manifest
strongli
h
treatment
probabl
necessari
provid
ifn
feed
water
time
per
day
livestock
industri
histori
adapt
new
use
technolog
automat
system
product
balanc
ration
anim
food
product
consumpt
wide
use
deliveri
microingredi
amino
acid
mycotoxin
binder
organ
acid
vitamin
trace
miner
batch
process
improv
accuraci
deliveri
microingredi
increas
effici
product
system
use
wide
manufactur
mani
beef
dairi
swine
poultri
feed
system
oper
control
unit
deliv
specifi
amountstyp
microingredi
milligram
microgram
per
head
per
day
weigh
premix
product
ration
base
intak
ppm
differ
micromachin
approv
fda
mix
fdaapprov
drug
diseas
improv
anim
effici
would
simpl
matter
determin
expect
feed
intak
per
anim
balanc
effect
dose
ifn
autom
deliveri
trial
ifn
alreadi
test
one
studi
deliv
hog
feed
control
porcin
reproduct
respiratori
syndrom
postwean
multisystem
wast
syndrom
amadori
et
al
studi
use
water
deliv
ifn
poultri
mice
fish
fleischmann
et
al
fleischmann
et
al
fulton
et
al
jarosinski
et
al
watanuki
et
al
collect
extens
vivo
data
demonstr
oral
administ
lowdos
ifn
rapid
system
benefici
biolog
effect
anim
human
present
studi
demonstr
oral
ifn
statist
modul
express
gene
within
specif
kegg
pathway
cytokinecytokin
receptor
interact
turn
data
suggest
lowdos
oral
ifn
exert
system
larg
benefici
antivir
effect
upor
downregul
specif
immun
respons
gene
product
like
need
recoveri
viral
diseas
includ
fmdv
accumul
evid
studi
suggest
adopt
oral
administ
bovin
therapeut
modal
suppress
viral
replic
livestock
risk
fmdv
exposur
inexpens
easili
dispens
wide
avail
altern
adjunct
vaccin
fmdv
addit
obviou
antivir
effect
oral
ifn
system
immun
modul
effect
also
part
overal
benefici
respons
ifn
latter
may
well
provid
prolong
system
benefici
effect
virussuscept
livestock
popul
result
intend
stimul
test
use
deliveri
feed
water
potenti
help
livestock
industri
manag
viral
respiratori
diseas
protect
fmdv
outbreak
